Drugs that block cancer blood vessel growth (anti angiogenics)
This page tells you about anti angiogenesis treatments (angiogenesis inhibitors). These are a type of biological therapy. There is information about
A cancer needs a good blood supply to bring food and oxygen and remove waste products. When it has reached 1 to 2mm across, a tumour needs to grow its own blood vessels in order to continue to get bigger. Some cancer cells make a protein called vascular endothelial growth factor (VEGF). The VEGF protein attaches to receptors on cells that line the walls of blood vessels within the tumour. The cells are called endothelial cells. This triggers the blood vessels to grow so the cancer can then grow.
Angiogenesis means the growth of new blood vessels. If we can stop cancers from growing blood vessels we can slow the growth of the cancer or sometimes shrink it. Anti angiogenic drugs are treatments that stop tumours from growing their own blood vessels.
There are different types of drugs that block blood vessel growth, including
- Drugs that block blood vessel growth factor
- Drugs that block signalling within the cell
- Drugs that affect signals between cells
Some drugs block vascular endothelial growth factor (VEGF) from attaching to the receptors on the cells that line the blood vessels. This stops the blood vessels from growing.
A drug that blocks VEGF is bevacizumab (Avastin). It is also a monoclonal antibody.
Sunitinib (Sutent) is a type of TKI that blocks the growth signals inside blood vessel cells. It is used to treat kidney cancer and a rare type of stomach cancer called gastrointestinal stromal tumour (GIST).
Some drugs act on the chemicals that cells use to signal to each other to grow. This can block the formation of blood vessels. Drugs that works in this way include thalidomide and lenalidomide (Revlimid).
Rated 5 out of 5 based on 2 votes
Question about cancer? Contact our information nurse team